Institutional investors hold a majority ownership of INCY through the 96.01% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $3.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 2.3 Million shares of Incyte Corp
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 1.4 Million shares of Incyte Corp
FIRST TRUST ADVISORS LP Bought 1.0 Million shares of Incyte Corp